As expected with caloric restriction and weight loss, there were significant improvements in several metabolic parameters between Day 1 and Day 20 including glycemic control, plasma lipids, and leptin that were similar in both groups (Table 2)
Rodents with induced hippocampal lesions, scopolamine-induced amnesia, or age-related cognitive decline show robust dose-dependent improvements
Current research focuses on how the peptide may support: Healthy cellular function Telomere maintenance Circadian rhythm regulation Healthy sleep Cellular repair Overall wellness during aging Although these findings are encouraging, larger human clinical studies are still needed to better understand the long-term effects and clinical applications of Epitalon peptide therapy
Only Vital Nutrients fills that specific role with GLP-1 Complete
Compare that to STEP 1 at 14.9% mean weight loss over 68 weeks, or SURMOUNT-1 at 20.9% over 72 weeks for the 15 mg tirzepatide dose
The researchers behind a systematic review of existing clinical trials concluded that the use of drugs in the GLP-1 RA class, like Ozempic, was associated with an increased risk of gallbladder diseases, according to a 2022 article published in the journal JAMA Internal Medicine